Trials / Completed
CompletedNCT00524264
A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 248 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a 16-day study to evaluate the safety and efficacy of ketorolac eye drops for the treatment of inflammation and pain associated with cataract surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ketorolac | Ophthalmic drops, BID pre- and post-operation, and 6 doses on surgery day. Placebo |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2008-04-01
- Completion
- 2008-04-01
- First posted
- 2007-09-03
- Last updated
- 2009-10-01
- Results posted
- 2009-10-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00524264. Inclusion in this directory is not an endorsement.